Outset Medical, Inc. (OM) stock
Close on Nov 13, 2026Market cap $70.11MP/E –Yield –
Outset Medical, Inc. grew revenue 1.6% to $121.97M over the twelve months to Sep 30, 2026. Free cash flow was -$42.89M. At the latest close the market valued the company at $70.11M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $70.11M
- P/E ratio
- –
- Price to sales
- 0.57
- Price to book
- 0.84
- Dividend yield
- –
- Free cash flow yield
- -61.17%
Fundamentals
- Revenue
- $121.97M
- Net income
- -$71.14M
- EPS, diluted
- -$5.37
- Free cash flow
- -$42.89M
- Book value per share
- $4424.30
- Diluted shares
- 0M
Trading
- Next earnings
- Jan 11, 2027 (estimated, before the open)
- Previous close
- $3.86
- Open
- $3.85
- Day's range
- $3.67 – $3.86
- Volume
- 59,425
- Average volume (20 days)
- 103,685
- Beta (5 years)
- 1.74
- 52-week range
- $2.84 – $6.49
- RSI (14 days)
- 42.4
- Volatility (1 year)
- 89.3%
- Relative volume
- 0.42×
- WACC
- 12.2%
On 2 of our idea lists: More cash than they're worth, Insiders buying the dip
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | OM | S&P 500 | Difference | OM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.1% | -3.0% | −5.1 pts | ||
| 3 months | -12.2% | -2.8% | −9.5 pts | ||
| Year to date | +0.5% | +11.5% | −10.9 pts | ||
| 1 year | -23.9% | +13.5% | −37.3 pts | ||
| 3 years | -94.1% | +77.7% | −171.8 pts | -61.1% | +21.1% |
| 5 years | -99.5% | +72.6% | −172.1 pts | -65.5% | +11.5% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Outset Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- Results
About Outset Medical
Electromedical & Electrotherapeutic Apparatus
Outset Medical, Inc. is a medical technology company that develops hemodialysis solutions to treat kidney failure, including acute kidney injury and end-stage renal disease. Its primary offering is the Tablo Hemodialysis System, an enterprise platform that integrates water purification and on-demand dialysate production into a compact mobile console. The company also provides the Tablo Cartridge, a single-use pre-strung consumable designed for treatment setup, as well as the TabloCart accessory. Through its Tablo Data Ecosystem, which encompasses TabloHub, MyTablo, and TabloDash, Outset Medical delivers cloud-based monitoring, patient analytics, and clinical recordkeeping. The system serves patients and healthcare providers across hospitals, clinics, and home settings.
Company profile, executives and historyOutset Medical stock: common questions
What is Outset Medical's stock price?
OM closed at $3.73 on Nov 13, 2026, down 3.37% on the day. Over the past 52 weeks it traded between $2.84 and $6.49.
What is Outset Medical's market cap?
Outset Medical was worth $70.11M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is OM's P/E ratio?
Outset Medical lost money over fiscal 2025 (diluted EPS -$5.37), so it has no meaningful P/E ratio.
How much revenue does Outset Medical make?
Outset Medical reported revenue of $121.97M for the twelve months to Sep 30, 2026, up 1.6% from a year earlier.
Does Outset Medical pay a dividend?
No. Outset Medical has not paid a cash dividend over the last twelve months.
When does Outset Medical report earnings next?
Outset Medical is expected to report Q4 FY2026 results on Jan 11, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has OM stock performed over the past year?
Including dividends, OM returned -23.9% over the past year, against +13.5% for the S&P 500.
How many OM shares are sold short?
1M shares were sold short at the latest FINRA report, 6.66% of the float, or 8.6 days of average trading volume.
Who are Outset Medical's competitors?
Companies most similar to Outset Medical by business, industry and size include CBLL, ELMD, IRIX, VASO, FOCL.
See a number that looks wrong?